| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/15/2004 | WO2004004728A1 Diarylmethylpiperazines as prophylactic or therapeutic agents for viral myocarditis |
| 01/15/2004 | WO2004004727A1 3,4-dihydroisoquinolin-1-one derivatives as inducers of apoptosis |
| 01/15/2004 | WO2004004726A1 Mchir antagonists |
| 01/15/2004 | WO2004004725A2 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| 01/15/2004 | WO2004004724A1 Novel pharmaceutical compositions comprising novel anticholinergic agents and nk1-receptor antagonists |
| 01/15/2004 | WO2004004723A1 Novel medicament combinations based on sodium channel blockers and magnesium salts |
| 01/15/2004 | WO2004004722A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(nk-1) antagonists for the treatment of emesis, depression, anxiety and cough |
| 01/15/2004 | WO2004004721A1 Use of ssri inhibitors to prevent or ameliorate trauma-related psychological disorders |
| 01/15/2004 | WO2004004720A1 3-`(hetero) arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors |
| 01/15/2004 | WO2004004719A1 Liquid dosage forms of non-enterically coated acid-labile drugs |
| 01/15/2004 | WO2004004718A1 Liquid dosage forms of acid labile drugs |
| 01/15/2004 | WO2004004717A1 Pharmaceutical composition comprising (s)-(+)-3-[1-[2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl]-1,2,3,6-tetrahydropyridin-4-yl]-6-chloro-1h-indole |
| 01/15/2004 | WO2004004716A1 Naphthalimide synthesis including amonafide synthesis and pharmaceutical preparations thereof |
| 01/15/2004 | WO2004004715A2 Novel delta opioid receptor ligands |
| 01/15/2004 | WO2004004713A1 Fredericamycin derivatives as medicaments for treating tumours |
| 01/15/2004 | WO2004004712A1 Methods of treating microbial infections in humans and animals |
| 01/15/2004 | WO2004004711A1 Use of at least two anticancer compounds, one of which at least modulates proteasome activity for making a medicine for cancer treatment |
| 01/15/2004 | WO2004004710A1 At1 receptor antagonists for preventing secondary strokes |
| 01/15/2004 | WO2004004709A1 Gel injection treatment of body parts |
| 01/15/2004 | WO2004004708A1 A pharmaceutical composition useful for treating chronic myeloid leukemia |
| 01/15/2004 | WO2004004707A1 Polymer affinity matrix, a method for the production and use thereof |
| 01/15/2004 | WO2004004705A2 Pharmaceutical formulations for preparing drink products |
| 01/15/2004 | WO2004004704A1 Novel pharmaceutical compositions comprising novel anticholinergic agents and pde-iv inhibitors |
| 01/15/2004 | WO2004004702A2 Method to inhibit ischemia and reperfusion injury |
| 01/15/2004 | WO2004004701A1 Remedy for urinary frequency and urinary incontinence |
| 01/15/2004 | WO2004004700A1 Methods for the treatment of sinusitis |
| 01/15/2004 | WO2004004699A2 Use of dantrolene, a ryanodine antagonist, in treating neural injury |
| 01/15/2004 | WO2004004698A2 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity |
| 01/15/2004 | WO2004004697A2 A novel use of rapamycin and structural analogues thereof |
| 01/15/2004 | WO2004004696A1 Controlled release composition |
| 01/15/2004 | WO2004004695A1 Extended-release tablets comprising divalproex sodium |
| 01/15/2004 | WO2004004694A1 Pharmaceutical dosage form bearing pregnancy-friendly indicia |
| 01/15/2004 | WO2004004692A1 Processes for the preparation of oral dosage formulations of modafinil |
| 01/15/2004 | WO2004004691A1 Phospholipid complexes of lexitropsins, their preparation and use in therapeutic formulations |
| 01/15/2004 | WO2004004690A1 Liquid dosage forms of proton pump inhibitors |
| 01/15/2004 | WO2004004689A1 Compositions and methods for amelioration of human female sexual dysfunction |
| 01/15/2004 | WO2004004686A2 Cartilage enhancing food supplements and methods of preparing the same |
| 01/15/2004 | WO2004004684A1 Controlled-release pharmaceutical formulations |
| 01/15/2004 | WO2004004683A1 Solid dispersions comprising two different polymer matrixes |
| 01/15/2004 | WO2004004682A2 Stable oily suspension of microgranules |
| 01/15/2004 | WO2004004665A2 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 01/15/2004 | WO2004004661A2 Boroproline compound combination therapy |
| 01/15/2004 | WO2004004660A2 Compositions and methods for the treatment of parkinson’s disease and tardive dyskinesias |
| 01/15/2004 | WO2004004658A2 Methods and compositions relating to isoleucine boroproline compounds |
| 01/15/2004 | WO2004004656A2 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
| 01/15/2004 | WO2004004655A2 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 01/15/2004 | WO2004004653A2 Methods for treating psychosis associated with interferon-alpha therapy |
| 01/15/2004 | WO2004004652A2 Mitotic kinesin binding site |
| 01/15/2004 | WO2004004651A2 Therapeutic amides |
| 01/15/2004 | WO2004004650A2 Antibacterial formulations |
| 01/15/2004 | WO2004004648A2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 01/15/2004 | WO2004004646A2 O-derivatized nocathiacin derivatives |
| 01/15/2004 | WO2004004644A2 Combination of mtor inhibitor and a tyrosine kinase inhibitor for the treatment of neoplasms |
| 01/15/2004 | WO2004004641A2 PKC ACTIVATION AS A MEANS FOR ENHANCING sAPPα SECRETION AND IMPROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS |
| 01/15/2004 | WO2004004638A2 Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects |
| 01/15/2004 | WO2004004634A2 Infertility treatment with exemestane |
| 01/15/2004 | WO2004004633A2 Use of tnfalpha antibodies and another drug |
| 01/15/2004 | WO2004004629A2 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 01/15/2004 | WO2004004603A1 Methods and devices for treating aneurysms |
| 01/15/2004 | WO2004004599A2 Epa and dha enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia |
| 01/15/2004 | WO2004004547A2 Method for colpoplasty |
| 01/15/2004 | WO2004004483A1 Vitamin-containing system for stabilising the immune response of animals |
| 01/15/2004 | WO2004004464A1 Novel rho inhibitors |
| 01/15/2004 | WO2004004456A1 Antimicrobial concentrates |
| 01/15/2004 | WO2004004451A1 Methods of screening compounds for grk6 modulating activity |
| 01/15/2004 | WO2003094950A8 A method of inhibiting the emigration of cells from the intravascular compartment into tissues |
| 01/15/2004 | WO2003094831A3 Novel diazabicyclic biaryl derivatives |
| 01/15/2004 | WO2003092608A3 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| 01/15/2004 | WO2003091247A3 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 01/15/2004 | WO2003090722A3 Microparticle pharmaceutical compositions for intratumoral delivery |
| 01/15/2004 | WO2003089434A3 IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES METHOD OF MAKING AND METHOD OF USE THEREOF |
| 01/15/2004 | WO2003088920A8 Low profile combination device for gastrostomy or jejunostomy applications having anti-granuloma formation characteristics |
| 01/15/2004 | WO2003084936A8 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological |
| 01/15/2004 | WO2003082216A3 Neuroprotectant methods, compositions, and screening methods thereof |
| 01/15/2004 | WO2003082191A3 Substituted 2,3-diphenyl pyridines |
| 01/15/2004 | WO2003080794A3 Inhibition of rna function by delivery of inhibitors to animal cells |
| 01/15/2004 | WO2003080118A3 Combination of an aldosterone receptor antagonist and a fibric acid derivative |
| 01/15/2004 | WO2003079969A3 Compositions and methods for treating and preventing necrosis |
| 01/15/2004 | WO2003072021A3 Oral pediatric trimethobenzamide formulations and methods |
| 01/15/2004 | WO2003070895A3 RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/15/2004 | WO2003068936A3 Inhibition of lung metastases by aerosol delivery of p53 gene and anti-cancer compounds |
| 01/15/2004 | WO2003066060A3 Use of tyrosine kinase inhibitors for the treatment of inflammatory processes |
| 01/15/2004 | WO2003064424A3 Water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases |
| 01/15/2004 | WO2003063904A3 Tissue adhesion formation control |
| 01/15/2004 | WO2003063783A3 Multiple virus replicon culture systems |
| 01/15/2004 | WO2003062191A8 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters |
| 01/15/2004 | WO2003061587A3 USE OF TGF-β ANTAGONISTS TO TREAT OR TO PREVENT CHRONIC TRANSPLANT REJECTION |
| 01/15/2004 | WO2003059274A3 Vitamin formulation for cardiovascular health |
| 01/15/2004 | WO2003055446A3 Antifungal phenethylene |
| 01/15/2004 | WO2003053401A3 Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules |
| 01/15/2004 | WO2003053350A3 Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability |
| 01/15/2004 | WO2003051296A3 Improved skin barrier function and cohesion through enhanced stratum corneum acidification |
| 01/15/2004 | WO2003049697A3 Treatment of glioblastoma with thymosin-alpha 1 |
| 01/15/2004 | WO2003049689A3 Isoflavone composition for oral delivery |
| 01/15/2004 | WO2003049682A3 Composition and method for treating chronic allograft rejection |
| 01/15/2004 | WO2003045307A3 Pharmaceutical formulations comprising indolinone derivatives |
| 01/15/2004 | WO2003042660A3 Screening method for predicting susceptibility to breast cancer |
| 01/15/2004 | WO2003039466A3 Method of treating estrogen responsive breast cancer |
| 01/15/2004 | WO2003023048A3 METHODS FOR DIAGNOSING AND TREATING DISEASES AND CONDITIONS ASSOCIATED WITH PROTEIN KINASE C$g(l) |
| 01/15/2004 | WO2002096866A3 Thiolalkyl benzoic acid derivatives |